Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 2
2006 3
2009 1
2010 1
2011 1
2014 3
2015 5
2016 1
2017 3
2018 3
2019 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database.
Collod-Béroud G, Le Bourdelles S, Ades L, Ala-Kokko L, Booms P, Boxer M, Child A, Comeglio P, De Paepe A, Hyland JC, Holman K, Kaitila I, Loeys B, Matyas G, Nuytinck L, Peltonen L, Rantamaki T, Robinson P, Steinmann B, Junien C, Béroud C, Boileau C. Collod-Béroud G, et al. Among authors: booms p. Hum Mutat. 2003 Sep;22(3):199-208. doi: 10.1002/humu.10249. Hum Mutat. 2003. PMID: 12938084 Review.
"Race for the Surface": Eukaryotic Cells Can Win.
Pham VT, Truong VK, Orlowska A, Ghanaati S, Barbeck M, Booms P, Fulcher AJ, Bhadra CM, Buividas R, Baulin V, Kirkpatrick CJ, Doran P, Mainwaring DE, Juodkazis S, Crawford RJ, Ivanova EP. Pham VT, et al. Among authors: booms p. ACS Appl Mater Interfaces. 2016 Aug 31;8(34):22025-31. doi: 10.1021/acsami.6b06415. Epub 2016 Aug 16. ACS Appl Mater Interfaces. 2016. PMID: 27494044
Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients - the randomized, EU-wide, placebo-controlled, phase II study design of IXION.
Kloka J, Friedrichson B, Dauth S, Foldenauer AC, Bulczak-Schadendorf A, Vehreschild MJGT, Matos FM, Riera-Mestre A, van Asselt ADI, De Robertis E, Juskeviciene VT, Meybohm P, Tomescu D, Lacombe K, Stehouwer CDA, Zacharowski K; IXION Collaboration Group. Kloka J, et al. Trials. 2022 Aug 19;23(1):688. doi: 10.1186/s13063-022-06609-x. Trials. 2022. PMID: 35986390 Free PMC article. Clinical Trial.
24 results